GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Iran Daru (XTEH:IRDR1) » Definitions » Total Assets

Iran Daru (XTEH:IRDR1) Total Assets : IRR0.00 Mil (As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Iran Daru Total Assets?

Iran Daru's Total Assets for the quarter that ended in . 20 was IRR0.00 Mil.

Total Assets is connected with ROA %. Iran Daru's annualized ROA % for the quarter that ended in . 20 was %. Total Assets is also linked to Revenue through Asset Turnover. Iran Daru's Asset Turnover for the quarter that ended in . 20 was .


Iran Daru Total Assets Historical Data

The historical data trend for Iran Daru's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Iran Daru Total Assets Chart

Iran Daru Annual Data
Trend
Total Assets

Iran Daru Semi-Annual Data
Total Assets

Iran Daru Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Iran Daru's Total Assets for the fiscal year that ended in . 20 is calculated as

Total Assets=Total Equity (A: . 20 )+Total Liabilities (A: . 20 )
=N/A+N/A
=N/A

Iran Daru's Total Assets for the quarter that ended in . 20 is calculated as

Total Assets=Total Equity (Q: . 20 )+Total Liabilities (Q: . 20 )
=N/A+N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Iran Daru  (XTEH:IRDR1) Total Assets Explanation

Total Assets is connected with ROA %.

Iran Daru's annualized ROA % for the quarter that ended in . 20 is

ROA %=Net Income (Q: . 20 )/( (Total Assets (Q: . 20 )+Total Assets (Q: . 20 ))/ count )
=/( (+)/ )
=/
= %

Note: The Net Income data used here is one times the annual (. 20) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Iran Daru's Asset Turnover for the quarter that ended in . 20 is

Asset Turnover
=Revenue (Q: . 20 )/( (Total Assets (Q: . 20 )+Total Assets (Q: . 20 ))/ count )
=/( (+)/ )
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Iran Daru Total Assets Related Terms

Thank you for viewing the detailed overview of Iran Daru's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Iran Daru (XTEH:IRDR1) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Ayatollah Saeedi Highway, End Of Kermani Street, Moallem Boulevard, Tehran, IRN, 1371658111
Iran Daru is a pharmaceutical company based in Iran. It manufactures and sells pharmaceutical products for antibiotics, cardiovascular agents, and local anesthetic agents. The company manufactures products in three main dosage form categories namely solid, semi-solid, and liquid including tablets, capsules, pellets, sachets, gels, creams, ointments (sterile and non-sterile), spray solutions, and syrups. Products offered by Iran Daru include Diclofenac Potassium, Biotin 5 mg, Tetracycline, Folic acid, Meloxicam, Acetaminophen and Caffeine, and Levocetirizine dihydrochloride, among others. It also exports its products to other countries.

Iran Daru (XTEH:IRDR1) Headlines

No Headlines